Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Infectious Disease Reports
Erschienen in: Current Infectious Disease Reports 2/2013

01.04.2013 | Genitourinary Infections (J Sobel, Section Editor)

Prevention and Treatment of Urinary Catheter-Associated Infections

verfasst von: Mayar Al Mohajer, Rabih O. Darouiche

Erschienen in: Current Infectious Disease Reports | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Catheter-associated urinary tract infections (CA-UTIs) are the most common nosocomial infection worldwide. Prolonged catheterization is the most important risk factor for CA-UTIs. As is the case with all device-related infections, the biofilm plays a central role in the pathogenesis of CA-UTIs. The diagnosis is often difficult, given the lack of good diagnostic tests. The most effective way to prevent infection is to limit catheter use and discontinue the catheter when no longer needed. Catheter removal or exchange is also useful in management. This review summarizes and analyzes the results of published studies of CA-UTIs and assesses the role of prevention approaches and management strategies.
Literatur
1.
Weinstein RA. Health-care associated infections. In: Kasper DL, Fauci AS, editors. Harrison’s infectious diseases. China: McGraw-Hill Companies Inc; 2010. p. 144–53.
2.
•• Siddiq DM, Darouiche RO. New strategies to prevent catheter-associated urinary tract infections. Nat Rev Urol. 2012;9(6):305–14. This article provides important information on the prevention of CA-UTI.PubMedCrossRef
3.
Smith PW, Bennett G, Bradley S, et al. SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008. Infect Control Hosp Epidemiol. 2008;29(9):785–814.PubMedCrossRef
4.
Hooton TM. Nosocomial Urinary Tract Infections. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett’s principles and practice of infectious diseases, vol. 2. 7th ed. Philadelphia: Elsevier Inc; 2010. p. 3725–37.CrossRef
5.
Haley RW, Hooton TM, Culver DH, et al. Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. Am J Med. 1981;70(4):947–59.PubMedCrossRef
6.
•• Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(5):625–63. These guidelines provide very important information on prevention and management of CA-UTI.PubMedCrossRef
7.
Nicolle LE. Urinary catheter-associated infections. Infect Dis Clin North Am. 2012;26(1):13–27.PubMedCrossRef
8.
9.
Warren JW, Tenney JH, Hoopes JM, et al. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis. 1982;146(6):719–23.PubMedCrossRef
10.
Saint S, Chenoweth CE. Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am. 2003;17(2):411–32.PubMedCrossRef
11.
Jacobsen SM, Stickler DJ, Mobley HL, et al. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev. 2008;21(1):26–59.PubMedCrossRef
12.
Maki DG, Tambyah PA. Engineering out the risk for infection with urinary catheters. Emerg Infect Dis. 2001;7(2):342–7.PubMedCrossRef
13.
Garibaldi RA, Burke JP, Dickman ML, et al. Factors predisposing to bacteriuria during indwelling urethral catheterization. N Engl J Med. 1974;291(5):215–9.PubMedCrossRef
14.
Garibaldi RA, Burke JP, Britt MR, et al. Meatal colonization and catheter-associated bacteriuria. N Engl J Med. 1980;303(6):316–8.PubMedCrossRef
15.
Platt R, Polk BF, Murdock B, et al. Risk factors for nosocomial urinary tract infection. Am J Epidemiol. 1986;124(6):977–85.PubMed
16.
Bakke A, Digranes A, Høisaeter PA. Physical predictors of infection in patients treated with clean intermittent catheterization: a prospective 7-year study. Br J Urol. 1997;79(1):85–90.PubMedCrossRef
17.
Bakke A, Vollset SE. Risk factors for bacteriuria and clinical urinary tract infection in patients treated with clean intermittent catheterization. J Urol. 1993;149(3):527–31.PubMed
18.
Tambyah PA, Maki DG. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch Intern Med. 2000;160(5):678–82.PubMedCrossRef
19.
Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005;40(5):643–54.PubMedCrossRef
20.
Griffiths R, Fernandez R. Strategies for the removal of short-term indwelling urethral catheters in adults. Cochrane Database Syst Rev. 2007;2:CD004011.PubMed
21.
Phipps S, Lim YN, McClinton S, et al. Short term urinary catheter policies following urogenital surgery in adults. Cochrane Database Syst Rev. 2006;2:CD004374.PubMed
22.
Gokula RR, Hickner JA, Smith MA. Inappropriate use of urinary catheters in elderly patients at a midwestern community teaching hospital. Am J Infect Control. 2004;32(4):196–9.PubMedCrossRef
23.
Garibaldi RA, Mooney BR, Epstein BJ, et al. An evaluation of daily bacteriologic monitoring to identify preventable episodes of catheter-associated urinary tract infection. Infect Control. 1982;3(6):466–70.PubMed
24.
Goetz AM, Kedzuf S, Wagener M, et al. Feedback to nursing staff as an intervention to reduce catheter-associated urinary tract infections. Am J Infect Control. 1999;27(5):402–4.PubMedCrossRef
25.
Rosenthal VD, Guzman S, Safdar N. Effect of education and performance feedback on rates of catheter-associated urinary tract infection in intensive care units in Argentina. Infect Control Hosp Epidemiol. 2004;25(1):47–50.PubMedCrossRef
26.
Apisarnthanarak A, Thongphubeth K, Sirinvaravong S, et al. Effectiveness of multifaceted hospitalwide quality improvement programs featuring an intervention to remove unnecessary urinary catheters at a tertiary care center in Thailand. Infect Control Hosp Epidemiol. 2007;28(7):791–8.PubMedCrossRef
27.
• Bruminhent J, Keegan M, Lakhani A, et al. Effectiveness of a simple intervention for prevention of catheter-associated urinary tract infections in a community teaching hospital. Am J Infect Control. 2010;38(9):689–93. This article provides important information on the use of reminder stickers in preventing CA-UTI.PubMedCrossRef
28.
Blodgett TJ. Reminder systems to reduce the duration of indwelling urinary catheters: a narrative review. Urol Nurs. 2009;29(5):369–78. quiz 379.PubMed
29.
Meddings J, Rogers MA, Macy M, et al. Systematic review and meta-analysis: reminder systems to reduce catheter-associated urinary tract infections and urinary catheter use in hospitalized patients. Clin Infect Dis. 2010;51(5):550–60.PubMedCrossRef
30.
Saint S, Kaufman SR, Rogers MA, et al. Condom versus indwelling urinary catheters: a randomized trial. J Am Geriatr Soc. 2006;54(7):1055–61.PubMedCrossRef
31.
Niël-Weise BS, van den Broek PJ. Urinary catheter policies for short-term bladder drainage in adults. Cochrane Database Syst Rev. 2005;3:CD004203.PubMed
32.
Tambyah PA, Halvorson KT, Maki DG. A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc. 1999;74(2):131–6.PubMedCrossRef
33.
Carapeti EA, Andrews SM, Bentley PG. Randomised study of sterile versus non-sterile urethral catheterisation. Ann R Coll Surg Engl. 1996;78(1):59–60.PubMed
34.
Lo E, Nicolle L, Classen D, et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 Suppl 1:S41–50.PubMedCrossRef
35.
Kass EH. Asymptomatic infections of the urinary tract. Trans Assoc Am Phys. 1956;69:56–64.PubMed
36.
Kunin CM, McCormack RC. Prevention of catheter-induced urinary-tract infections by sterile closed drainage. N Engl J Med. 1966;274(21):1155–61.PubMedCrossRef
37.
Rutala WA, Kennedy VA, Loflin HB, et al. Serratia marcescens nosocomial infections of the urinary tract associated with urine measuring containers and urinometers. Am J Med. 1981;70(3):659–63.PubMedCrossRef
38.
Crnich CJ, Drinka PJ. Does the composition of urinary catheters influence clinical outcomes and the results of research studies? Infect Control Hosp Epidemiol. 2007;28(1):102–3.PubMedCrossRef
39.
Srinivasan A, Karchmer T, Richards A, et al. A prospective trial of a novel, silicone-based, silver-coated foley catheter for the prevention of nosocomial urinary tract infections. Infect Control Hosp Epidemiol. 2006;27(1):38–43.PubMedCrossRef
40.
Stensballe J, Tvede M, Looms D, et al. Infection risk with nitrofurazone-impregnated urinary catheters in trauma patients: a randomized trial. Ann Intern Med. 2007;147(5):285–93.PubMed
41.
Schumm K, Lam TB. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev. 2008;2:CD004013.PubMed
42.
Pickard R, Lam T, Maclennan G, et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet. 2012 Nov 2.
43.
Seymour C. Audit of catheter-associated UTI using silver alloy-coated Foley catheters. Br J Nurs. 2006;15(11):598–603.PubMed
44.
Rupp ME, Fitzgerald T, Marion N, et al. Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. Am J Infect Control. 2004;32(8):445–50.PubMedCrossRef
45.
Lee SJ, Kim SW, Cho YH, et al. A comparative multicentre study on the incidence of catheter-associated urinary tract infection between nitrofurazone-coated and silicone catheters. Int J Antimicrob Agents. 2004;24 Suppl 1:S65–9.PubMedCrossRef
46.
Al-Habdan I, Sadat-Ali M, Corea JR, et al. Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. Int Surg. 2003;88(3):152–4.PubMed
47.
Lai KK, Fontecchio SA. Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients. Am J Infect Control. 2002;30(4):221–5.PubMedCrossRef
48.
Newton T, Still JM, Law E. A comparison of the effect of early insertion of standard latex and silver-impregnated latex foley catheters on urinary tract infections in burn patients. Infect Control Hosp Epidemiol. 2002;23(4):217–8.PubMedCrossRef
49.
Karchmer TB, Giannetta ET, Muto CA, et al. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med. 2000;160(21):3294–8.PubMedCrossRef
50.
Thibon P, Le Coutour X, Leroyer R, et al. Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections. J Hosp Infect. 2000;45(2):117–24.PubMedCrossRef
51.
Bologna RA, Tu LM, Polansky M, et al. Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study. Urology. 1999;54(6):982–7.PubMedCrossRef
52.
Verleyen P, De Ridder D, Van Poppel H, et al. Clinical application of the Bardex IC Foley catheter. Eur Urol. 1999;36(3):240–6.PubMedCrossRef
53.
Liedberg H, Lundeberg T, Ekman P. Refinements in the coating of urethral catheters reduces the incidence of catheter-associated bacteriuria. An experimental and clinical study. Eur Urol. 1990;17(3):236–40.PubMed
54.
Liedberg H, Lundeberg T. Silver alloy coated catheters reduce catheter-associated bacteriuria. Br J Urol. 1990;65(4):379–81.PubMedCrossRef
55.
Saint S, Lipsky BA. Preventing catheter-related bacteriuria: should we? Can we? How? Arch Intern Med. 1999;159(8):800–8.PubMedCrossRef
56.
Petronella P, Scorzelli M, Fiore A, et al. Antibiotic prophylaxis in catheter-associated urinary infections. New Microbiol. 2012;35(2):191–8.PubMed
57.
Rutschmann OT, Zwahlen A, et al. Use of norfloxacin for prevention of symptomatic urinary tract infection in chronically catheterized patients. Eur J Clin Microbiol Infect Dis. 1995;14(5):441–4.PubMedCrossRef
58.
Gribble MJ, Puterman ML. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole. Am J Med. 1993;95(2):141–52.PubMedCrossRef
59.
•• Darouiche RO, Hull RA. Bacterial interference for prevention of urinary tract infection. Clin Infect Dis. 2012;55(10):1400–7. This article provides very important information on the use of bacterial interference for preventing catheter-related urinary tract infections.PubMedCrossRef
60.
Hull RA, Rudy DC, Donovan WH, et al. Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria. Infect Immun. 1999;67(1):429–32.PubMed
61.
Darouiche RO, Green BG, Donovan WH, et al. Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder. Urology. 2011;78(2):341–6.PubMedCrossRef
62.
Sobel JD, Kauffman CA, McKinsey D, et al. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis. 2000;30(1):19–24.PubMedCrossRef
63.
• Trautner BW. Management of catheter-associated urinary tract infection. Curr Opin Infect Dis. 2010;23(1):76–82. This article provide important information on the management of CA-UTI and medicare rule changes in the USA.PubMedCrossRef
64.
Leone M, Perrin AS, Granier I, et al. A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients. Intensive Care Med. 2007;33(4):726–9.PubMedCrossRef
65.
Warren JW, Anthony WC, Hoopes JM, et al. Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. JAMA. 1982;248(4):454–8.PubMedCrossRef
66.
Maynard FM, Diokno AC. Urinary infection and complications during clean intermittent catheterization following spinal cord injury. J Urol. 1984;132(5):943–6.PubMed
67.
Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329(18):1328–34.PubMedCrossRef
68.
Bergqvist D, Brönnestam R, Hedelin H, et al. The relevance of urinary sampling methods in patients with indwelling Foley catheters. Br J Urol. 1980;52(2):92–5.PubMedCrossRef
69.
Tenney JH, Warren JW. Bacteriuria in women with long-term catheters: paired comparison of indwelling and replacement catheters. J Infect Dis. 1988;157(1):199–202.PubMedCrossRef
70.
Raz R, Schiller D, Nicolle LE. Chronic indwelling catheter replacement before antimicrobial therapy for symptomatic urinary tract infection. J Urol. 2000;164(4):1254–8.PubMedCrossRef
71.
Peterson J, Kaul S, Khashab M, et al. A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Urology. 2008;71(1):17–22.PubMedCrossRef
Metadaten
Titel
Prevention and Treatment of Urinary Catheter-Associated Infections
verfasst von
Mayar Al Mohajer
Rabih O. Darouiche
Publikationsdatum
01.04.2013
Verlag
Current Science Inc.
Erschienen in
Current Infectious Disease Reports / Ausgabe 2/2013
Print ISSN: 1523-3847
Elektronische ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-013-0316-6

Weitere Artikel der Ausgabe 2/2013

Current Infectious Disease Reports 2/2013 Zur Ausgabe

RESPIRATORY INFECTIONS (F ARNOLD, SECTION EDITOR)

Determining the Duration of Therapy for Patients with Community-Acquired Pneumonia

GENITOURINARY INFECTIONS (J SOBEL, SECTION EDITOR)

Genetic Basis for Recurrent Vulvo-Vaginal Candidiasis

RESPIRATORY INFECTIONS (F ARNOLD, SECTION EDITOR)

Is Prolonged Low-Dose Glucocorticoid Treatment Beneficial in Community-Acquired Pneumonia?

RESPIRATORY INFECTIONS (F ARNOLD, SECTION EDITOR)

Viral Infections in Children with Community-Acquired Pneumonia

Hot Topic

Fecal Bacteriotherapy for Recurrent Clostridium difficile Infection: What’s Old Is New Again?

RESPIRATORY INFECTIONS (F ARNOLD, SECTION EDITOR)

Epidemiologic and Clinical Implications of Second-Generation Pneumococcal Conjugate Vaccines

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO2. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Zeitschrift für Allgemeinmedizin, DEGAM

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise